| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.092 | 0.1 |